nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Parkinson's disease—Memantine—Alzheimer's disease	0.35	0.5	CpDpCtD
Tolcapone—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.35	0.5	CpDpCtD
Tolcapone—CYP2C9—Donepezil—Alzheimer's disease	0.0791	1	CbGbCtD
Tolcapone—COMT—telencephalic ventricle—Alzheimer's disease	0.00268	0.495	CbGeAlD
Tolcapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—Alzheimer's disease	0.00263	0.101	CbGpPWpGaD
Tolcapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—Alzheimer's disease	0.00229	0.0878	CbGpPWpGaD
Tolcapone—COMT—Dopamine metabolism—MAOB—Alzheimer's disease	0.00221	0.0845	CbGpPWpGaD
Tolcapone—COMT—Biogenic Amine Synthesis—CHAT—Alzheimer's disease	0.00205	0.0786	CbGpPWpGaD
Tolcapone—COMT—Biogenic Amine Synthesis—ACHE—Alzheimer's disease	0.00159	0.061	CbGpPWpGaD
Tolcapone—COMT—Dopamine metabolism—SOD1—Alzheimer's disease	0.00127	0.0485	CbGpPWpGaD
Tolcapone—Tolmetin—MPO—Alzheimer's disease	0.000969	0.493	CrCbGaD
Tolcapone—COMT—forebrain—Alzheimer's disease	0.000699	0.129	CbGeAlD
Tolcapone—COMT—telencephalon—Alzheimer's disease	0.000643	0.119	CbGeAlD
Tolcapone—Tolmetin—PTGS1—Alzheimer's disease	0.000635	0.323	CrCbGaD
Tolcapone—CYP2C9—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.000481	0.0184	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP46A1—Alzheimer's disease	0.000469	0.0179	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000462	0.0177	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000446	0.0171	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000431	0.0165	CbGpPWpGaD
Tolcapone—COMT—nervous system—Alzheimer's disease	0.000379	0.0701	CbGeAlD
Tolcapone—COMT—central nervous system—Alzheimer's disease	0.000365	0.0675	CbGeAlD
Tolcapone—Tolmetin—PTGS2—Alzheimer's disease	0.000363	0.185	CrCbGaD
Tolcapone—COMT—cerebellum—Alzheimer's disease	0.000357	0.066	CbGeAlD
Tolcapone—COMT—Neuronal System—SLC18A3—Alzheimer's disease	0.000331	0.0127	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000304	0.0116	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000304	0.0116	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	0.000298	0.0114	CbGpPWpGaD
Tolcapone—COMT—brain—Alzheimer's disease	0.00029	0.0536	CbGeAlD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000287	0.011	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—MAOB—Alzheimer's disease	0.00028	0.0107	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000279	0.0107	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000276	0.0106	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000258	0.0099	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000258	0.0099	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA7—Alzheimer's disease	0.000233	0.00892	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIK1—Alzheimer's disease	0.000233	0.00892	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.00023	0.00882	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000226	0.00867	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000218	0.00835	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—PTGS1—Alzheimer's disease	0.000212	0.00811	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP2D6—Alzheimer's disease	0.000208	0.00796	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000205	0.00785	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.0002	0.00768	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000198	0.00759	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIK2—Alzheimer's disease	0.000198	0.00758	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHAT—Alzheimer's disease	0.000198	0.00758	CbGpPWpGaD
Tolcapone—Discomfort—Galantamine—Alzheimer's disease	0.000177	0.00095	CcSEcCtD
Tolcapone—Haematuria—Rivastigmine—Alzheimer's disease	0.000177	0.000948	CcSEcCtD
Tolcapone—COMT—Neuronal System—GRIA1—Alzheimer's disease	0.000177	0.00676	CbGpPWpGaD
Tolcapone—Dry mouth—Galantamine—Alzheimer's disease	0.000175	0.00094	CcSEcCtD
Tolcapone—Epistaxis—Rivastigmine—Alzheimer's disease	0.000175	0.000938	CcSEcCtD
Tolcapone—Tinnitus—Donepezil—Alzheimer's disease	0.000175	0.000937	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000175	0.00669	CbGpPWpGaD
Tolcapone—Sinusitis—Rivastigmine—Alzheimer's disease	0.000174	0.000933	CcSEcCtD
Tolcapone—Confusional state—Galantamine—Alzheimer's disease	0.000173	0.000929	CcSEcCtD
Tolcapone—Bradycardia—Memantine—Alzheimer's disease	0.000173	0.000929	CcSEcCtD
Tolcapone—Haemoglobin—Memantine—Alzheimer's disease	0.000171	0.000917	CcSEcCtD
Tolcapone—Rhinitis—Memantine—Alzheimer's disease	0.000171	0.000915	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.00017	0.00653	CbGpPWpGaD
Tolcapone—Haemorrhage—Memantine—Alzheimer's disease	0.00017	0.000912	CcSEcCtD
Tolcapone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000169	0.000909	CcSEcCtD
Tolcapone—Hypoaesthesia—Memantine—Alzheimer's disease	0.000169	0.000908	CcSEcCtD
Tolcapone—Hallucination—Memantine—Alzheimer's disease	0.000169	0.000908	CcSEcCtD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000169	0.00648	CbGpPWpGaD
Tolcapone—Shock—Galantamine—Alzheimer's disease	0.000169	0.000906	CcSEcCtD
Tolcapone—Pharyngitis—Memantine—Alzheimer's disease	0.000169	0.000906	CcSEcCtD
Tolcapone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000168	0.000904	CcSEcCtD
Tolcapone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000168	0.000902	CcSEcCtD
Tolcapone—Chills—Donepezil—Alzheimer's disease	0.000168	0.000902	CcSEcCtD
Tolcapone—Urinary tract disorder—Memantine—Alzheimer's disease	0.000168	0.000901	CcSEcCtD
Tolcapone—Tachycardia—Galantamine—Alzheimer's disease	0.000168	0.000899	CcSEcCtD
Tolcapone—Oedema peripheral—Memantine—Alzheimer's disease	0.000168	0.000899	CcSEcCtD
Tolcapone—Arrhythmia—Donepezil—Alzheimer's disease	0.000167	0.000898	CcSEcCtD
Tolcapone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000167	0.000897	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNB2—Alzheimer's disease	0.000167	0.0064	CbGpPWpGaD
Tolcapone—Rhinitis—Rivastigmine—Alzheimer's disease	0.000167	0.000895	CcSEcCtD
Tolcapone—Skin disorder—Galantamine—Alzheimer's disease	0.000167	0.000895	CcSEcCtD
Tolcapone—Urethral disorder—Memantine—Alzheimer's disease	0.000167	0.000894	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000167	0.00638	CbGpPWpGaD
Tolcapone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000166	0.000893	CcSEcCtD
Tolcapone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000166	0.000891	CcSEcCtD
Tolcapone—Hallucination—Rivastigmine—Alzheimer's disease	0.000166	0.000888	CcSEcCtD
Tolcapone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000166	0.000888	CcSEcCtD
Tolcapone—Alopecia—Donepezil—Alzheimer's disease	0.000166	0.000888	CcSEcCtD
Tolcapone—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000165	0.000886	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000165	0.00631	CbGpPWpGaD
Tolcapone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000164	0.000882	CcSEcCtD
Tolcapone—Mental disorder—Donepezil—Alzheimer's disease	0.000164	0.00088	CcSEcCtD
Tolcapone—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000164	0.000879	CcSEcCtD
Tolcapone—Anorexia—Galantamine—Alzheimer's disease	0.000164	0.000878	CcSEcCtD
Tolcapone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000163	0.000875	CcSEcCtD
Tolcapone—Erythema multiforme—Memantine—Alzheimer's disease	0.000161	0.000863	CcSEcCtD
Tolcapone—Flatulence—Donepezil—Alzheimer's disease	0.000161	0.000862	CcSEcCtD
Tolcapone—Hypotension—Galantamine—Alzheimer's disease	0.00016	0.000861	CcSEcCtD
Tolcapone—Tension—Donepezil—Alzheimer's disease	0.00016	0.000858	CcSEcCtD
Tolcapone—Dysgeusia—Donepezil—Alzheimer's disease	0.00016	0.000857	CcSEcCtD
Tolcapone—Tinnitus—Memantine—Alzheimer's disease	0.000159	0.000851	CcSEcCtD
Tolcapone—Nervousness—Donepezil—Alzheimer's disease	0.000158	0.00085	CcSEcCtD
Tolcapone—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000157	0.000844	CcSEcCtD
Tolcapone—Muscle spasms—Donepezil—Alzheimer's disease	0.000157	0.000841	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000156	0.000839	CcSEcCtD
Tolcapone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000155	0.000832	CcSEcCtD
Tolcapone—Angiopathy—Memantine—Alzheimer's disease	0.000154	0.000828	CcSEcCtD
Tolcapone—Paraesthesia—Galantamine—Alzheimer's disease	0.000154	0.000827	CcSEcCtD
Tolcapone—Vision blurred—Donepezil—Alzheimer's disease	0.000154	0.000824	CcSEcCtD
Tolcapone—COMT—Neuronal System—ACHE—Alzheimer's disease	0.000154	0.00588	CbGpPWpGaD
Tolcapone—Mediastinal disorder—Memantine—Alzheimer's disease	0.000153	0.000822	CcSEcCtD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000153	0.00586	CbGpPWpGaD
Tolcapone—Tremor—Donepezil—Alzheimer's disease	0.000153	0.00082	CcSEcCtD
Tolcapone—Somnolence—Galantamine—Alzheimer's disease	0.000153	0.000819	CcSEcCtD
Tolcapone—Chills—Memantine—Alzheimer's disease	0.000153	0.000819	CcSEcCtD
Tolcapone—Arrhythmia—Memantine—Alzheimer's disease	0.000152	0.000815	CcSEcCtD
Tolcapone—COMT—Neuronal System—CHRNA4—Alzheimer's disease	0.000152	0.00581	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000151	0.000812	CcSEcCtD
Tolcapone—Dyspepsia—Galantamine—Alzheimer's disease	0.000151	0.000811	CcSEcCtD
Tolcapone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000151	0.00081	CcSEcCtD
Tolcapone—Anaemia—Donepezil—Alzheimer's disease	0.000151	0.000809	CcSEcCtD
Tolcapone—Alopecia—Memantine—Alzheimer's disease	0.00015	0.000806	CcSEcCtD
Tolcapone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00015	0.000805	CcSEcCtD
Tolcapone—Agitation—Donepezil—Alzheimer's disease	0.00015	0.000804	CcSEcCtD
Tolcapone—Chills—Rivastigmine—Alzheimer's disease	0.000149	0.000801	CcSEcCtD
Tolcapone—Decreased appetite—Galantamine—Alzheimer's disease	0.000149	0.000801	CcSEcCtD
Tolcapone—Mental disorder—Memantine—Alzheimer's disease	0.000149	0.000799	CcSEcCtD
Tolcapone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000149	0.000797	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000148	0.000795	CcSEcCtD
Tolcapone—Fatigue—Galantamine—Alzheimer's disease	0.000148	0.000794	CcSEcCtD
Tolcapone—Malaise—Donepezil—Alzheimer's disease	0.000147	0.000789	CcSEcCtD
Tolcapone—Alopecia—Rivastigmine—Alzheimer's disease	0.000147	0.000789	CcSEcCtD
Tolcapone—Constipation—Galantamine—Alzheimer's disease	0.000147	0.000788	CcSEcCtD
Tolcapone—Vertigo—Donepezil—Alzheimer's disease	0.000147	0.000786	CcSEcCtD
Tolcapone—Syncope—Donepezil—Alzheimer's disease	0.000146	0.000785	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000146	0.0056	CbGpPWpGaD
Tolcapone—Flatulence—Memantine—Alzheimer's disease	0.000146	0.000783	CcSEcCtD
Tolcapone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000146	0.000782	CcSEcCtD
Tolcapone—Tension—Memantine—Alzheimer's disease	0.000145	0.000779	CcSEcCtD
Tolcapone—Dysgeusia—Memantine—Alzheimer's disease	0.000145	0.000778	CcSEcCtD
Tolcapone—Nervousness—Memantine—Alzheimer's disease	0.000144	0.000772	CcSEcCtD
Tolcapone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000143	0.000769	CcSEcCtD
Tolcapone—Flatulence—Rivastigmine—Alzheimer's disease	0.000143	0.000766	CcSEcCtD
Tolcapone—Cough—Donepezil—Alzheimer's disease	0.000142	0.000763	CcSEcCtD
Tolcapone—Tension—Rivastigmine—Alzheimer's disease	0.000142	0.000763	CcSEcCtD
Tolcapone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000142	0.000761	CcSEcCtD
Tolcapone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000142	0.000759	CcSEcCtD
Tolcapone—Hypertension—Donepezil—Alzheimer's disease	0.000141	0.000755	CcSEcCtD
Tolcapone—Nervousness—Rivastigmine—Alzheimer's disease	0.000141	0.000755	CcSEcCtD
Tolcapone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00014	0.000753	CcSEcCtD
Tolcapone—Vision blurred—Memantine—Alzheimer's disease	0.00014	0.000749	CcSEcCtD
Tolcapone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000139	0.000747	CcSEcCtD
Tolcapone—Myalgia—Donepezil—Alzheimer's disease	0.000139	0.000745	CcSEcCtD
Tolcapone—Chest pain—Donepezil—Alzheimer's disease	0.000139	0.000745	CcSEcCtD
Tolcapone—Arthralgia—Donepezil—Alzheimer's disease	0.000139	0.000745	CcSEcCtD
Tolcapone—Tremor—Memantine—Alzheimer's disease	0.000139	0.000744	CcSEcCtD
Tolcapone—Anxiety—Donepezil—Alzheimer's disease	0.000138	0.000742	CcSEcCtD
Tolcapone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000137	0.000737	CcSEcCtD
Tolcapone—Discomfort—Donepezil—Alzheimer's disease	0.000137	0.000736	CcSEcCtD
Tolcapone—Anaemia—Memantine—Alzheimer's disease	0.000137	0.000734	CcSEcCtD
Tolcapone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000137	0.000732	CcSEcCtD
Tolcapone—Agitation—Memantine—Alzheimer's disease	0.000136	0.00073	CcSEcCtD
Tolcapone—Dry mouth—Donepezil—Alzheimer's disease	0.000136	0.000728	CcSEcCtD
Tolcapone—Abdominal pain—Galantamine—Alzheimer's disease	0.000136	0.000728	CcSEcCtD
Tolcapone—Body temperature increased—Galantamine—Alzheimer's disease	0.000136	0.000728	CcSEcCtD
Tolcapone—Tremor—Rivastigmine—Alzheimer's disease	0.000136	0.000728	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000135	0.00517	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000134	0.000721	CcSEcCtD
Tolcapone—Confusional state—Donepezil—Alzheimer's disease	0.000134	0.00072	CcSEcCtD
Tolcapone—Anaemia—Rivastigmine—Alzheimer's disease	0.000134	0.000718	CcSEcCtD
Tolcapone—COMT—Neuronal System—BCHE—Alzheimer's disease	0.000134	0.00512	CbGpPWpGaD
Tolcapone—Malaise—Memantine—Alzheimer's disease	0.000134	0.000716	CcSEcCtD
Tolcapone—Agitation—Rivastigmine—Alzheimer's disease	0.000133	0.000714	CcSEcCtD
Tolcapone—Oedema—Donepezil—Alzheimer's disease	0.000133	0.000714	CcSEcCtD
Tolcapone—Vertigo—Memantine—Alzheimer's disease	0.000133	0.000714	CcSEcCtD
Tolcapone—Syncope—Memantine—Alzheimer's disease	0.000133	0.000712	CcSEcCtD
Tolcapone—Infection—Donepezil—Alzheimer's disease	0.000132	0.000709	CcSEcCtD
Tolcapone—Shock—Donepezil—Alzheimer's disease	0.000131	0.000702	CcSEcCtD
Tolcapone—Palpitations—Memantine—Alzheimer's disease	0.000131	0.000702	CcSEcCtD
Tolcapone—Malaise—Rivastigmine—Alzheimer's disease	0.000131	0.000701	CcSEcCtD
Tolcapone—COMT—Neuronal System—DLG4—Alzheimer's disease	0.000131	0.005	CbGpPWpGaD
Tolcapone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000131	0.0007	CcSEcCtD
Tolcapone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00013	0.000699	CcSEcCtD
Tolcapone—Vertigo—Rivastigmine—Alzheimer's disease	0.00013	0.000698	CcSEcCtD
Tolcapone—Loss of consciousness—Memantine—Alzheimer's disease	0.00013	0.000698	CcSEcCtD
Tolcapone—Syncope—Rivastigmine—Alzheimer's disease	0.00013	0.000697	CcSEcCtD
Tolcapone—Cough—Memantine—Alzheimer's disease	0.000129	0.000693	CcSEcCtD
Tolcapone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000129	0.00069	CcSEcCtD
Tolcapone—Palpitations—Rivastigmine—Alzheimer's disease	0.000128	0.000687	CcSEcCtD
Tolcapone—Hypertension—Memantine—Alzheimer's disease	0.000128	0.000686	CcSEcCtD
Tolcapone—COMT—Neuronal System—GRIN2B—Alzheimer's disease	0.000128	0.00489	CbGpPWpGaD
Tolcapone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000127	0.000683	CcSEcCtD
Tolcapone—Anorexia—Donepezil—Alzheimer's disease	0.000127	0.000681	CcSEcCtD
Tolcapone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000127	0.000679	CcSEcCtD
Tolcapone—Cough—Rivastigmine—Alzheimer's disease	0.000126	0.000678	CcSEcCtD
Tolcapone—COMT—Neuronal System—PLCB1—Alzheimer's disease	0.000126	0.00483	CbGpPWpGaD
Tolcapone—Myalgia—Memantine—Alzheimer's disease	0.000126	0.000676	CcSEcCtD
Tolcapone—Chest pain—Memantine—Alzheimer's disease	0.000126	0.000676	CcSEcCtD
Tolcapone—Arthralgia—Memantine—Alzheimer's disease	0.000126	0.000676	CcSEcCtD
Tolcapone—Anxiety—Memantine—Alzheimer's disease	0.000126	0.000674	CcSEcCtD
Tolcapone—Hypertension—Rivastigmine—Alzheimer's disease	0.000125	0.000671	CcSEcCtD
Tolcapone—Discomfort—Memantine—Alzheimer's disease	0.000125	0.000668	CcSEcCtD
Tolcapone—Hypotension—Donepezil—Alzheimer's disease	0.000124	0.000667	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000124	0.00474	CbGpPWpGaD
Tolcapone—Myalgia—Rivastigmine—Alzheimer's disease	0.000123	0.000662	CcSEcCtD
Tolcapone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000123	0.000662	CcSEcCtD
Tolcapone—Chest pain—Rivastigmine—Alzheimer's disease	0.000123	0.000662	CcSEcCtD
Tolcapone—Dry mouth—Memantine—Alzheimer's disease	0.000123	0.000661	CcSEcCtD
Tolcapone—Asthenia—Galantamine—Alzheimer's disease	0.000123	0.000661	CcSEcCtD
Tolcapone—Anxiety—Rivastigmine—Alzheimer's disease	0.000123	0.000659	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000122	0.000657	CcSEcCtD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000122	0.00468	CbGpPWpGaD
Tolcapone—Confusional state—Memantine—Alzheimer's disease	0.000122	0.000654	CcSEcCtD
Tolcapone—Discomfort—Rivastigmine—Alzheimer's disease	0.000122	0.000654	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000122	0.00467	CbGpPWpGaD
Tolcapone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000121	0.000651	CcSEcCtD
Tolcapone—Oedema—Memantine—Alzheimer's disease	0.000121	0.000648	CcSEcCtD
Tolcapone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000121	0.000647	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.00012	0.00461	CbGpPWpGaD
Tolcapone—COMT—Metabolism—DHCR24—Alzheimer's disease	0.00012	0.0046	CbGpPWpGaD
Tolcapone—Infection—Memantine—Alzheimer's disease	0.00012	0.000644	CcSEcCtD
Tolcapone—Paraesthesia—Donepezil—Alzheimer's disease	0.00012	0.000641	CcSEcCtD
Tolcapone—Confusional state—Rivastigmine—Alzheimer's disease	0.000119	0.000639	CcSEcCtD
Tolcapone—Shock—Memantine—Alzheimer's disease	0.000119	0.000638	CcSEcCtD
Tolcapone—Dyspnoea—Donepezil—Alzheimer's disease	0.000119	0.000637	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000119	0.00454	CbGpPWpGaD
Tolcapone—Nervous system disorder—Memantine—Alzheimer's disease	0.000119	0.000636	CcSEcCtD
Tolcapone—Somnolence—Donepezil—Alzheimer's disease	0.000118	0.000635	CcSEcCtD
Tolcapone—Thrombocytopenia—Memantine—Alzheimer's disease	0.000118	0.000635	CcSEcCtD
Tolcapone—Oedema—Rivastigmine—Alzheimer's disease	0.000118	0.000634	CcSEcCtD
Tolcapone—Tachycardia—Memantine—Alzheimer's disease	0.000118	0.000633	CcSEcCtD
Tolcapone—Diarrhoea—Galantamine—Alzheimer's disease	0.000118	0.00063	CcSEcCtD
Tolcapone—Infection—Rivastigmine—Alzheimer's disease	0.000117	0.00063	CcSEcCtD
Tolcapone—Skin disorder—Memantine—Alzheimer's disease	0.000117	0.00063	CcSEcCtD
Tolcapone—Dyspepsia—Donepezil—Alzheimer's disease	0.000117	0.000629	CcSEcCtD
Tolcapone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000117	0.000627	CcSEcCtD
Tolcapone—Shock—Rivastigmine—Alzheimer's disease	0.000116	0.000624	CcSEcCtD
Tolcapone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000116	0.000622	CcSEcCtD
Tolcapone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000116	0.000621	CcSEcCtD
Tolcapone—Decreased appetite—Donepezil—Alzheimer's disease	0.000116	0.000621	CcSEcCtD
Tolcapone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000115	0.000619	CcSEcCtD
Tolcapone—Anorexia—Memantine—Alzheimer's disease	0.000115	0.000618	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000115	0.000616	CcSEcCtD
Tolcapone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000115	0.000616	CcSEcCtD
Tolcapone—Fatigue—Donepezil—Alzheimer's disease	0.000115	0.000616	CcSEcCtD
Tolcapone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000114	0.000613	CcSEcCtD
Tolcapone—Constipation—Donepezil—Alzheimer's disease	0.000114	0.000611	CcSEcCtD
Tolcapone—Pain—Donepezil—Alzheimer's disease	0.000114	0.000611	CcSEcCtD
Tolcapone—Dizziness—Galantamine—Alzheimer's disease	0.000114	0.000609	CcSEcCtD
Tolcapone—Hypotension—Memantine—Alzheimer's disease	0.000113	0.000606	CcSEcCtD
Tolcapone—Anorexia—Rivastigmine—Alzheimer's disease	0.000113	0.000605	CcSEcCtD
Tolcapone—Hypotension—Rivastigmine—Alzheimer's disease	0.00011	0.000593	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00011	0.000591	CcSEcCtD
Tolcapone—Feeling abnormal—Donepezil—Alzheimer's disease	0.00011	0.000588	CcSEcCtD
Tolcapone—Vomiting—Galantamine—Alzheimer's disease	0.000109	0.000586	CcSEcCtD
Tolcapone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000109	0.000584	CcSEcCtD
Tolcapone—Paraesthesia—Memantine—Alzheimer's disease	0.000109	0.000582	CcSEcCtD
Tolcapone—Rash—Galantamine—Alzheimer's disease	0.000108	0.000581	CcSEcCtD
Tolcapone—Dermatitis—Galantamine—Alzheimer's disease	0.000108	0.00058	CcSEcCtD
Tolcapone—Dyspnoea—Memantine—Alzheimer's disease	0.000108	0.000578	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000108	0.000578	CcSEcCtD
Tolcapone—Headache—Galantamine—Alzheimer's disease	0.000108	0.000577	CcSEcCtD
Tolcapone—Somnolence—Memantine—Alzheimer's disease	0.000107	0.000576	CcSEcCtD
Tolcapone—Dyspepsia—Memantine—Alzheimer's disease	0.000106	0.000571	CcSEcCtD
Tolcapone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000106	0.000569	CcSEcCtD
Tolcapone—Urticaria—Donepezil—Alzheimer's disease	0.000106	0.000567	CcSEcCtD
Tolcapone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000105	0.000565	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000105	0.00404	CbGpPWpGaD
Tolcapone—Abdominal pain—Donepezil—Alzheimer's disease	0.000105	0.000564	CcSEcCtD
Tolcapone—Body temperature increased—Donepezil—Alzheimer's disease	0.000105	0.000564	CcSEcCtD
Tolcapone—Somnolence—Rivastigmine—Alzheimer's disease	0.000105	0.000564	CcSEcCtD
Tolcapone—Decreased appetite—Memantine—Alzheimer's disease	0.000105	0.000564	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000104	0.00056	CcSEcCtD
Tolcapone—Fatigue—Memantine—Alzheimer's disease	0.000104	0.000559	CcSEcCtD
Tolcapone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000104	0.000558	CcSEcCtD
Tolcapone—Pain—Memantine—Alzheimer's disease	0.000103	0.000554	CcSEcCtD
Tolcapone—Constipation—Memantine—Alzheimer's disease	0.000103	0.000554	CcSEcCtD
Tolcapone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000103	0.000551	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000102	0.00392	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CA4—Alzheimer's disease	0.000102	0.00391	CbGpPWpGaD
Tolcapone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000102	0.000548	CcSEcCtD
Tolcapone—Nausea—Galantamine—Alzheimer's disease	0.000102	0.000547	CcSEcCtD
Tolcapone—Fatigue—Rivastigmine—Alzheimer's disease	0.000102	0.000547	CcSEcCtD
Tolcapone—Pain—Rivastigmine—Alzheimer's disease	0.000101	0.000542	CcSEcCtD
Tolcapone—Constipation—Rivastigmine—Alzheimer's disease	0.000101	0.000542	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.0001	0.00385	CbGpPWpGaD
Tolcapone—Feeling abnormal—Memantine—Alzheimer's disease	9.96e-05	0.000534	CcSEcCtD
Tolcapone—Gastrointestinal pain—Memantine—Alzheimer's disease	9.88e-05	0.00053	CcSEcCtD
Tolcapone—Hypersensitivity—Donepezil—Alzheimer's disease	9.81e-05	0.000526	CcSEcCtD
Tolcapone—Feeling abnormal—Rivastigmine—Alzheimer's disease	9.74e-05	0.000523	CcSEcCtD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	9.69e-05	0.00371	CbGpPWpGaD
Tolcapone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	9.67e-05	0.000519	CcSEcCtD
Tolcapone—Urticaria—Memantine—Alzheimer's disease	9.6e-05	0.000515	CcSEcCtD
Tolcapone—COMT—Metabolism—GAPDHS—Alzheimer's disease	9.6e-05	0.00368	CbGpPWpGaD
Tolcapone—Abdominal pain—Memantine—Alzheimer's disease	9.55e-05	0.000512	CcSEcCtD
Tolcapone—Body temperature increased—Memantine—Alzheimer's disease	9.55e-05	0.000512	CcSEcCtD
Tolcapone—Asthenia—Donepezil—Alzheimer's disease	9.55e-05	0.000512	CcSEcCtD
Tolcapone—Pruritus—Donepezil—Alzheimer's disease	9.42e-05	0.000505	CcSEcCtD
Tolcapone—Urticaria—Rivastigmine—Alzheimer's disease	9.39e-05	0.000504	CcSEcCtD
Tolcapone—Body temperature increased—Rivastigmine—Alzheimer's disease	9.35e-05	0.000501	CcSEcCtD
Tolcapone—Abdominal pain—Rivastigmine—Alzheimer's disease	9.35e-05	0.000501	CcSEcCtD
Tolcapone—COMT—Neuronal System—PRKCG—Alzheimer's disease	9.33e-05	0.00357	CbGpPWpGaD
Tolcapone—Diarrhoea—Donepezil—Alzheimer's disease	9.11e-05	0.000489	CcSEcCtD
Tolcapone—COMT—Metabolism—ATP5A1—Alzheimer's disease	9.1e-05	0.00349	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	9.02e-05	0.00346	CbGpPWpGaD
Tolcapone—Hypersensitivity—Memantine—Alzheimer's disease	8.9e-05	0.000478	CcSEcCtD
Tolcapone—Dizziness—Donepezil—Alzheimer's disease	8.8e-05	0.000472	CcSEcCtD
Tolcapone—Hypersensitivity—Rivastigmine—Alzheimer's disease	8.71e-05	0.000467	CcSEcCtD
Tolcapone—COMT—Metabolism—PLD3—Alzheimer's disease	8.68e-05	0.00333	CbGpPWpGaD
Tolcapone—Asthenia—Memantine—Alzheimer's disease	8.67e-05	0.000465	CcSEcCtD
Tolcapone—Pruritus—Memantine—Alzheimer's disease	8.55e-05	0.000459	CcSEcCtD
Tolcapone—Asthenia—Rivastigmine—Alzheimer's disease	8.48e-05	0.000455	CcSEcCtD
Tolcapone—Vomiting—Donepezil—Alzheimer's disease	8.46e-05	0.000454	CcSEcCtD
Tolcapone—Rash—Donepezil—Alzheimer's disease	8.39e-05	0.00045	CcSEcCtD
Tolcapone—Dermatitis—Donepezil—Alzheimer's disease	8.39e-05	0.00045	CcSEcCtD
Tolcapone—Pruritus—Rivastigmine—Alzheimer's disease	8.37e-05	0.000449	CcSEcCtD
Tolcapone—Headache—Donepezil—Alzheimer's disease	8.34e-05	0.000447	CcSEcCtD
Tolcapone—COMT—Metabolism—HSD17B10—Alzheimer's disease	8.32e-05	0.00319	CbGpPWpGaD
Tolcapone—Diarrhoea—Memantine—Alzheimer's disease	8.27e-05	0.000444	CcSEcCtD
Tolcapone—Diarrhoea—Rivastigmine—Alzheimer's disease	8.09e-05	0.000434	CcSEcCtD
Tolcapone—COMT—Neuronal System—CALM1—Alzheimer's disease	8.08e-05	0.00309	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP46A1—Alzheimer's disease	8.01e-05	0.00307	CbGpPWpGaD
Tolcapone—Dizziness—Memantine—Alzheimer's disease	7.99e-05	0.000429	CcSEcCtD
Tolcapone—Nausea—Donepezil—Alzheimer's disease	7.91e-05	0.000424	CcSEcCtD
Tolcapone—Dizziness—Rivastigmine—Alzheimer's disease	7.82e-05	0.000419	CcSEcCtD
Tolcapone—COMT—Metabolism—ND1—Alzheimer's disease	7.74e-05	0.00296	CbGpPWpGaD
Tolcapone—Vomiting—Memantine—Alzheimer's disease	7.68e-05	0.000412	CcSEcCtD
Tolcapone—Rash—Memantine—Alzheimer's disease	7.62e-05	0.000409	CcSEcCtD
Tolcapone—Dermatitis—Memantine—Alzheimer's disease	7.61e-05	0.000408	CcSEcCtD
Tolcapone—Headache—Memantine—Alzheimer's disease	7.57e-05	0.000406	CcSEcCtD
Tolcapone—Vomiting—Rivastigmine—Alzheimer's disease	7.52e-05	0.000403	CcSEcCtD
Tolcapone—Rash—Rivastigmine—Alzheimer's disease	7.45e-05	0.0004	CcSEcCtD
Tolcapone—Dermatitis—Rivastigmine—Alzheimer's disease	7.45e-05	0.0004	CcSEcCtD
Tolcapone—Headache—Rivastigmine—Alzheimer's disease	7.41e-05	0.000397	CcSEcCtD
Tolcapone—Nausea—Memantine—Alzheimer's disease	7.18e-05	0.000385	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	7.18e-05	0.00275	CbGpPWpGaD
Tolcapone—Nausea—Rivastigmine—Alzheimer's disease	7.02e-05	0.000377	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	6.92e-05	0.00265	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CREB1—Alzheimer's disease	6.91e-05	0.00265	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	5.6e-05	0.00214	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	5.44e-05	0.00208	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	5.33e-05	0.00204	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.26e-05	0.00201	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	5.01e-05	0.00192	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CHAT—Alzheimer's disease	4.99e-05	0.00191	CbGpPWpGaD
Tolcapone—COMT—Metabolism—TPI1—Alzheimer's disease	4.99e-05	0.00191	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MAOB—Alzheimer's disease	4.78e-05	0.00183	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.62e-05	0.00177	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GAPDH—Alzheimer's disease	4.6e-05	0.00176	CbGpPWpGaD
Tolcapone—COMT—Metabolism—A2M—Alzheimer's disease	4.44e-05	0.0017	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ACHE—Alzheimer's disease	3.87e-05	0.00148	CbGpPWpGaD
Tolcapone—COMT—Metabolism—INPP5D—Alzheimer's disease	3.82e-05	0.00146	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS1—Alzheimer's disease	3.62e-05	0.00139	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ENO1—Alzheimer's disease	3.62e-05	0.00139	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2D6—Alzheimer's disease	3.55e-05	0.00136	CbGpPWpGaD
Tolcapone—COMT—Metabolism—BCHE—Alzheimer's disease	3.37e-05	0.00129	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PLCB1—Alzheimer's disease	3.18e-05	0.00122	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	3.08e-05	0.00118	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCA1—Alzheimer's disease	3.08e-05	0.00118	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.87e-05	0.0011	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARGC1A—Alzheimer's disease	2.66e-05	0.00102	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HMOX1—Alzheimer's disease	2.64e-05	0.00101	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.62e-05	0.001	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.56e-05	0.000981	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.46e-05	0.000944	CbGpPWpGaD
Tolcapone—COMT—Metabolism—LPL—Alzheimer's disease	2.42e-05	0.000926	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.34e-05	0.000895	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.23e-05	0.000854	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.23e-05	0.000854	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.2e-05	0.000844	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTHFR—Alzheimer's disease	2.18e-05	0.000834	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.14e-05	0.000818	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.09e-05	0.0008	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	2.06e-05	0.000788	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CALM1—Alzheimer's disease	2.03e-05	0.000779	CbGpPWpGaD
Tolcapone—COMT—Metabolism—APOE—Alzheimer's disease	2.03e-05	0.000776	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CAV1—Alzheimer's disease	2.01e-05	0.000769	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.99e-05	0.000761	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.94e-05	0.000744	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.78e-05	0.00068	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARG—Alzheimer's disease	1.77e-05	0.000676	CbGpPWpGaD
Tolcapone—COMT—Metabolism—INS—Alzheimer's disease	1.73e-05	0.000663	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.53e-05	0.000586	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NOS3—Alzheimer's disease	1.52e-05	0.000581	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.39e-05	0.000534	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS2—Alzheimer's disease	1.39e-05	0.000532	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.28e-05	0.00049	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.28e-05	0.00049	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.23e-05	0.00047	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.18e-05	0.000453	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.17e-05	0.000447	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.16e-05	0.000443	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.14e-05	0.000437	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.02e-05	0.00039	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACHE—Alzheimer's disease	9.93e-06	0.00038	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	9.81e-06	0.000376	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	9.3e-06	0.000356	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ENO1—Alzheimer's disease	9.3e-06	0.000356	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	9.12e-06	0.000349	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—BCHE—Alzheimer's disease	8.65e-06	0.000331	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	8.16e-06	0.000313	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8e-06	0.000307	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.91e-06	0.000303	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—Alzheimer's disease	6.98e-06	0.000267	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.82e-06	0.000261	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.79e-06	0.00026	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LPL—Alzheimer's disease	6.21e-06	0.000238	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.59e-06	0.000214	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CALM1—Alzheimer's disease	5.22e-06	0.0002	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—APOE—Alzheimer's disease	5.2e-06	0.000199	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CAV1—Alzheimer's disease	5.15e-06	0.000197	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.53e-06	0.000174	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—INS—Alzheimer's disease	4.44e-06	0.00017	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.9e-06	0.000149	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.56e-06	0.000137	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.79e-06	6.86e-05	CbGpPWpGaD
